- Home
- About Us
- Industry
- Innovation
- Market
- Products
-
Responsibility
Responsibility
-
Contact
Contact
Categroies
Sorafenib tosylate
1. Treatment of inoperable advanced renal cell carcinoma.<br>
2. Treatment of primary hepatocellular carcinoma that is inoperable or distantly metastasized.
2. Treatment of primary hepatocellular carcinoma that is inoperable or distantly metastasized.
Dabrafenib
is a kinase inhibitor indicated for the treatment of patients with unresectable or metastatic melanoma with a BRAF V600E mutation detected by an FDA-approved test.
Sitagliptin phosphate
This product is used in combination with diet control and exercise to improve blood sugar control in patients with type 2 diabetes.
Regorafenib
1. It is suitable for the treatment of metastatic colorectal cancer who have previously received chemotherapy based on fluorouracil, oxaliplatin and irinotecan, and who have previously received or are not suitable for anti-VEGF therapy and anti-EGFR therapy (RAS wild type) (mCRC) patients.<br>
2. Patients with locally advanced, unresectable or metastatic gastrointestinal stromal tumor (GIST) who have previously received imatinib mesylate and sunitinib malate.<br>
3. Hepatocellular carcinoma (HCC) patients who have previously received sorafenib treatment.
2. Patients with locally advanced, unresectable or metastatic gastrointestinal stromal tumor (GIST) who have previously received imatinib mesylate and sunitinib malate.<br>
3. Hepatocellular carcinoma (HCC) patients who have previously received sorafenib treatment.
Isradipine
Hypertension, coronary atherosclerotic heart disease, angina pectoris, and congestive heart failure.
Dapagliflozin
ARXIGA is a sodium-glucose cotransporter 2 (SGLT2) inhibitor indicated for use as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes.
Doxazosin Mesylate
1. Primary mild to moderate hypertension. For patients whose blood pressure is difficult to control with single medication, it can be used in combination with diuretics, beta-blockers, calcium antagonists or angiotensin-converting enzyme inhibitors (ACEI).<br>
2. Symptomatic treatment of benign prostatic hyperplasia.
2. Symptomatic treatment of benign prostatic hyperplasia.
Lansoprazole
For the treatment of duodenal ulcer, gastric ulcer, anastomotic ulcer, reflux esophagitis and gastrinoma.
Dexlansoprazole
It is used for the treatment of duodenal ulcer, gastric ulcer, reflux esophagitis and gastrinoma, and has inhibitory effect on Helicobacter pylori.
Ritonavir
Alone or in combination with antiretroviral nucleoside drugs to treat advanced or non-progressive AIDS patients.
Lopinavir
It is suitable for use in combination with other antiretroviral drugs to treat HIV infection.
Tenofovir alafenamide
For the treatment of patients with chronic hepatitis B virus (HBV) infection with compensated liver disease.
Emtricitabine
1. Combined with other antiviral drugs for the treatment of HIV-1 infection in adults. Patients who have not been treated with reverse transcriptase inhibitors and who have been suppressed after treatment with reverse transcriptase inhibitors. <br>
2. For the treatment of chronic hepatitis B.
2. For the treatment of chronic hepatitis B.
Previous page
1
2
…
6
Next page
Mobile
+8613637076726 
Contact 